You are here: Industry Insights > Corporate Affairs

News List

LEO Pharma and Elektrofi Expand Partnership to Co-Develop New Antibodies with the Aim of Achieving Improvements in Drug Delivery within Dermatology firstwordpharma
April 10, 2019
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology and Elektrofi, a Boston- based biotechnology company focused on drug formulation and delivery innovations...
Novartis seeks to further tap into Chinese healthcare market firstwordpharma
April 03, 2019
Novartis CEO Vas Narasimhan indicated that the drugmaker aims to boost its presence in China by launching new products in the country and enhancing collaborations with local biotechnology and technology firms to...
Eli Lilly inks deal with ImmuNext to jointly develop therapies for autoimmune diseases firstwordpharma
March 28, 2019
Eli Lilly and ImmuNext announced a collaboration to jointly study a preclinical novel target that could facilitate the development of new treatments for autoimmune disorders that regulate immune cell metabolism.
Abeona Therapeutics Announces CEO Transition firstwordpharma
November 27, 2018
Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases
AstraZeneca begins succession planning for CEO Soriot: report firstwordpharma
November 19, 2018
AstraZeneca has started looking for candidates to succeed CEO Pascal Soriot amid pressure from shareholders, reported the Sunday Times without citing sources.
Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units firstwordpharma
November 19, 2018
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a "best efforts" public offering of units consisting of one share of common stock
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer firstwordpharma
November 15, 2018
CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s Chief Financial Officer
NW Bio Announces $5 Million Bridge Funding firstwordpharma
November 14, 2018
Northwest Biotherapeutics (OTCQB: NWBO) -- ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers
Proteostasis Therapeutics Prices Public Offering of Common Stock firstwordpharma
October 25, 2018
Proteostasis Therapeutics Prices Public Offering of Common Stock
Spero Therapeutics Announces Proposed Offering of Common Stock firstwordpharma
July 10, 2018
Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections

Previous page 1 2 Next page